Cargando…
Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761(®): A Case Series
Case series Patients: Male, 33-year-old • Female, 26-year-old • Female, 32-year-old • Female, 26-year-old • Male, 59-year-old Final Diagnosis: Post-COVID-19 cognitive deficits Symptoms: Memory loss • concentration difficulties Medication: EGb 761(®) Clinical Procedure: Individual basis Specialty: Ne...
Autores principales: | Zifko, Udo A., Yacob, Muhammad, Braun, Benedikt J., Dietz, Gunnar P.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523733/ https://www.ncbi.nlm.nih.gov/pubmed/36156538 http://dx.doi.org/10.12659/AJCR.937094 |
Ejemplares similares
-
Antiapoptotic Effects of EGb 761
por: Serrano-García, Norma, et al.
Publicado: (2013) -
Ginkgo biloba leaf extract EGb 761(®) as a paragon of the product by process concept
por: Kulić, Žarko, et al.
Publicado: (2022) -
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®))
por: Tomino, Carlo, et al.
Publicado: (2021) -
The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008) -
A Detailed View on the Proanthocyanidins in Ginkgo Extract EGb 761
por: Kulić, Žarko, et al.
Publicado: (2021)